Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein
Nangola Sawitree, Urvoas Agathe, Valerio-Lepiniec Marie and 6 more
Retrovirology · 2012
doi:10.1186/1742-4690-9-17 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p>Ankyrins are cellular mediators of a number of essential protein-protein interactions. Unlike intrabodies, ankyrins are composed of highly structured repeat modules characterized by disulfide bridge-independent folding. Artificial ankyrin molecules, designed to target viral components, might act as intracellular antiviral agents and contribute to the cellular immunity against viral pathogens such as HIV-1.</p> <p>Results</p> <p>A phage-displayed library of artificial ankyrins was constructed, and screened on a polyprotein made of the fused matrix and capsid domains (MA-CA) of the HIV-1 Gag precursor. An ankyrin with three modules named Ank<sup>GAG</sup>1D4 (16.5 kDa) was isolated. Ank<sup>GAG</sup>1D4 and MA-CA formed a protein complex with a stoichiometry of 1:1 and a dissociation constant of <it>K</it><sub>d </sub>~ 1 μM, and the Ank<sup>GAG</sup>1D4 binding site was mapped to the N-terminal domain of the CA, within residues 1-110. HIV-1 production in SupT1 cells stably expressing Ank<sup>GAG</sup>1D4 in both N-myristoylated and non-N-myristoylated versions was significantly reduced compared to control cells. Ank<sup>GAG</sup>1D4 expression also reduced the production of MLV, a phylogenetically distant retrovirus. The Ank<sup>GAG</sup>1D4-mediated antiviral effect on HIV-1 was found to occur at post-integration steps, but did not involve the Gag precursor processing or cellular trafficking. Our data suggested that the lower HIV-1 progeny yields resulted from the negative interference of Ank<sup>GAG</sup>1D4-CA with the Gag assembly and budding pathway.</p> <p>Conclusions</p> <p>The resistance of Ank<sup>GAG</sup>1D4-expressing cells to HIV-1 suggested that the CA-targeted ankyrin Ank<sup>GAG</sup>1D4 could serve as a protein platform for the design of a novel class of intracellular inhibitors of HIV-1 assembly based on ankyrin-repeat modules.</p>
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.